Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: Nutr Cancer. 2018 May 21;70(5):804–820. doi: 10.1080/01635581.2018.1470653

Table 2.

Grouping and classification of breast cancer diagnoses.

TNBC relevancya Intrinsic subtypesb Receptor statusb

Does not include TNBC diagnoses Luminal A ER+
Luminal B PR+
HER2-enriched ER+ and PR+
ER+ and PR+ and HER2−
ER+ and PR+ and HER2+
HER2+

May include TNBC diagnosesc ER−
PR−
ER− and PR−
HER2−

TNBC diagnoses Basald ER−PR−HER2−

Abbreviations: ER – Estrogen Receptor, PR – Progesterone Receptor, TNBC – Triple Negative Breast Cancer, HER2 – Human Epidermal growth factor Receptor 2.

a

Breast cancer diagnoses grouping according to relevancy of TNBC.

b

Ways in which breast cancer diagnoses were categorized in results included in this review.

c

Diagnoses which did not report all three receptor statuses (ER, PR, HER2) prevent definitive determination of TNBC status.

d

Cancers identified as basal are assumed to be TNBC.